Reata Pharma (RETA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RETA | AMGN | BMY | GILD | VRTX |
| Company | Reata Pharma | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 172.34 | 270.50 | 50.30 | 79.58 | 353.46 |
| High | 172.46 | 273.41 | 51.00 | 79.81 | 355.19 |
| Low | 172.32 | 266.63 | 49.99 | 77.85 | 349.29 |
| Last | 172.36 | 271.27 | 50.20 | 78.05 | 353.58 |
| Change | +0.04 | +1.92 | +0.32 | -1.31 | +0.12 |
| % Change | +0.02% | +0.71% | +0.64% | -1.65% | +0.03% |
| Volume | 1,988,500 | 1,176,424 | 8,831,191 | 5,103,571 | 444,336 |
| 20-Day Average Volume | 810,510 | 2,045,221 | 13,504,150 | 6,138,924 | 1,430,552 |
| Previous Close | 172.32 | 269.35 | 49.88 | 79.36 | 353.46 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 170.84 | 267.81 | 49.90 | 76.05 | 355.88 |
| 20-Day Raw Stochastic | 97.36% | 75.66% | 46.86% | 65.35% | 28.57% |
| 20-Day Relative Strength | 81.56% | 53.04% | 42.03% | 53.40% | 47.05% |
| Weighted Alpha | +177.60 | +3.89 | -37.13 | -8.94 | +12.58 |
| Today's Opinion | 100% Buy | 72% Buy | 88% Sell | 32% Sell | 24% Buy |
| Previous Opinion | 100% Buy | 56% Buy | 100% Sell | 16% Sell | 24% Buy |
| Last Month's Opinion | 100% Buy | 72% Buy | 100% Sell | 24% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.18% since 09/18/23 | +0.57% since 11/30/23 | +1.81% since 11/30/23 | +1.87% since 11/30/23 | -0.44% since 11/30/23 |
| Low | 171.96 on 09/19/23 | 266.63 on 12/07/23 | 48.93 on 12/01/23 | 76.20 on 12/01/23 | 347.51 on 12/04/23 |
| High | 172.46 on 09/25/23 | 273.43 on 12/04/23 | 51.00 on 12/07/23 | 80.18 on 12/06/23 | 356.71 on 12/01/23 |
| 1-Month | |||||
| %Chg | +1.99% since 08/25/23 | +0.03% since 11/07/23 | -3.85% since 11/07/23 | -3.19% since 11/07/23 | -6.61% since 11/07/23 |
| Low | 168.67 on 09/05/23 | 260.52 on 11/21/23 | 48.25 on 11/30/23 | 73.99 on 11/16/23 | 341.90 on 11/16/23 |
| High | 172.46 on 09/25/23 | 274.77 on 11/08/23 | 52.58 on 11/08/23 | 80.18 on 12/06/23 | 381.59 on 11/14/23 |
| 3-Month | |||||
| %Chg | +83.77% since 06/23/23 | +6.60% since 09/07/23 | -16.17% since 09/07/23 | +5.54% since 09/07/23 | +2.70% since 09/07/23 |
| Low | 88.80 on 06/27/23 | 249.70 on 10/31/23 | 48.25 on 11/30/23 | 72.87 on 10/03/23 | 341.85 on 10/03/23 |
| High | 172.46 on 09/25/23 | 288.46 on 10/13/23 | 61.42 on 09/11/23 | 82.59 on 11/03/23 | 387.42 on 11/06/23 |
| 6-Month | |||||
| %Chg | +101.14% since 03/24/23 | +22.57% since 06/07/23 | -22.84% since 06/07/23 | +2.57% since 06/07/23 | +8.81% since 06/07/23 |
| Low | 76.54 on 05/10/23 | 215.32 on 06/12/23 | 48.25 on 11/30/23 | 72.87 on 10/03/23 | 323.02 on 06/08/23 |
| High | 172.46 on 09/25/23 | 288.46 on 10/13/23 | 66.38 on 06/21/23 | 82.59 on 11/03/23 | 387.42 on 11/06/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,575,535 | 144,150,192 | 101,493,728 | 98,885,888 | 91,080,640 |
| Shares Outstanding, K | 38,150 | 535,178 | 2,034,758 | 1,246,042 | 257,683 |
| Annual Sales | 2,220,000 | 26,323,000,000 | 46,159,000,000 | 27,281,000,000 | 8,930,700,000 |
| Annual Net Income | -311,900,000 | 6,552,000,000 | 6,327,000,000 | 4,592,000,000 | 3,322,000,000 |
| Last Quarter Sales | 22,750,000 | 6,903,000,000 | 10,966,000,000 | 7,051,000,000 | 2,483,500,000 |
| Last Quarter Net Income | 193,000,000 | 1,730,000,000 | 1,928,000,000 | 2,180,000,000 | 1,035,300,000 |
| 60-Month Beta | 1.42 | 0.58 | 0.34 | 0.29 | 0.42 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.32 on 08/08/23 | 4.96 on 10/31/23 | 2.00 on 10/26/23 | 2.29 on 11/07/23 | 4.08 on 11/06/23 |
| Latest Earnings Date | 11/14/23 | 01/30/24 | 10/26/23 | 11/07/23 | 11/06/23 |
| Most Recent Dividend | N/A | 2.130 on 11/16/23 | 0.570 on 10/05/23 | 0.750 on 09/14/23 | N/A |
| Next Ex-Dividends Date | N/A | 11/16/23 | 10/05/23 | 12/14/23 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.02 | 6.59 | 11.85 | 26.83 |
